Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules

By Nabors G.S.   Braun P.A.   Herrmann D.J.   Heise M.L.   Pyle D.J.   Gravenstein S.   Schilling M.   Ferguson L.M.   Hollingshead S.K.   Briles D.E.   Becker R.S.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1743-1754

Elsevier

Access to resources Recommend Favorite

High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates

By Shokri F.   Jafarzadeh A.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4544-4548

Elsevier

Access to resources Recommend Favorite

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults

By Van Hoecke C.   Comberbach M.   De Grave D.   Desmons P.   Fu D.   Hauser P.   Lebacq E.   Lobet Y.   Voet P.  

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1620-1626

Elsevier

Access to resources Recommend Favorite

Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers

By Weber J.   Cheinsong-Popov R.   Callow D.   Adams S.   Patou G.   Hodgkin K.   Martin S.   Gotch F.   Kingsman A.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 831-834

Elsevier

Access to resources Recommend Favorite

Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design

By Herrera O.B.   Brett S.   Lechler R.I.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 231-242

Elsevier

Access to resources Recommend Favorite